A fluorescent dye developed by UK scientists at the University of Oxford could potentially revolutionize prostate cancer surgery. The dye attaches to a protein only found in cancer cells, helping surgeons identify and remove cancerous tissue more effectively. In a small trial, the dye enabled surgeons to detect cancer cells that would have been missed by conventional methods. A larger trial funded by Cancer Research UK is planned to further evaluate the effectiveness of this approach.
Lead researcher Prof Freddie Hamdy described the results as “promising,” noting that the dye allows for the visualization of fine details of prostate cancer during surgery. This real-time imaging could lead to more precise removal of cancer cells, reducing the risk of recurrence. Patients like David Butler, who participated in the trial, have benefited from this innovative technique, with one patient being cancer-free post-surgery.
Prostate cancer is the most common cancer in UK men. Dr. Iain Foulkes of CRUK expressed optimism about the potential impact of this research on improving cancer treatment. If successful, the dye could be adapted for use in surgery for other types of cancer.
